Quarterly
Annual
| Unit: USD | 2025-09-07 | 2025-06-15 | 2025-03-23 | 2024-12-29 | 2024-09-08 | 2024-06-16 | 2024-03-24 | 2023-12-31 | 2023-09-10 | 2023-06-18 | 2023-03-26 | 2023-01-01 | 2022-09-11 | 2022-06-19 | 2022-03-27 | 2022-01-02 | 2021-01-03 | 2019-12-29 | 2019-09-08 | 2018-12-30 | 2017-12-31 | 2017-01-01 | 2016-01-03 | 2014-12-28 | 2013-01-01 | 2011-12-28 | 2010-12-30 | 2008-12-31 | 2007-03-25 | 2006-12-28 | 2005-12-29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||||||||||||||||
net income | 139,319,000 | 131,091,000 | 149,651,000 | 169,444,000 | 146,924,000 | 141,978,000 | 125,824,000 | 157,292,000 | 147,676,000 | 109,380,000 | 104,770,000 | 158,302,000 | 100,504,000 | 102,493,000 | 90,964,000 | 155,685,000 | 86,373,000 | 93,327,000 | 72,733,000 | 62,759,000 | 48,033,000 | 68,171,000 | 13,467,000 | 16,000,000 | 11,026,000 | 8,398,000 | 33,100,000 | -6,888,000 | |||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||
depreciation and amortization | 20,415,000 | 20,351,000 | 20,362,000 | 26,758,000 | 20,756,000 | 20,349,000 | 19,869,000 | 25,641,000 | 18,268,000 | 18,561,000 | 18,170,000 | 24,225,000 | 18,933,000 | 18,117,000 | 18,976,000 | 22,704,000 | 13,132,000 | 14,315,000 | 12,680,000 | 9,739,000 | 15,764,000 | 9,931,000 | 6,974,000 | 7,639,000 | 7,660,000 | 7,249,000 | 10,025,000 | 9,465,000 | |||
refranchising (gain) loss | 0 | ||||||||||||||||||||||||||||||
loss on sale/disposal of assets | 91,000 | 346,000 | 266,000 | 1,026,000 | 174,000 | 237,000 | 90,000 | 752,000 | 145,000 | 127,000 | 275,000 | 1,338,000 | 27,000 | 253,000 | 195,000 | 696,000 | |||||||||||||||
amortization of debt issuance costs | 1,349,000 | 1,209,000 | 1,210,000 | 1,613,000 | 1,210,000 | 1,209,000 | 1,266,000 | 1,677,000 | 1,280,000 | 1,286,000 | 1,292,000 | 1,708,000 | 1,306,000 | 1,312,000 | 1,319,000 | 1,739,000 | 1,090,000 | 1,552,000 | 1,856,000 | ||||||||||||
benefit for deferred income taxes | 11,955,000 | -410,000 | -2,290,000 | -1,593,000 | -1,278,000 | -2,489,000 | -3,757,000 | -7,318,000 | -4,595,000 | -4,157,000 | -3,439,000 | -2,554,000 | -198,000 | ||||||||||||||||||
non-cash equity-based compensation expense | 10,325,000 | 10,975,000 | 10,381,000 | 11,714,000 | 9,517,000 | 10,686,000 | 11,338,000 | 11,007,000 | 9,442,000 | 9,527,000 | 7,538,000 | 7,119,000 | 5,852,000 | 8,473,000 | 7,265,000 | 9,217,000 | |||||||||||||||
excess tax benefits from equity-based compensation | -408,000 | -774,000 | -1,569,000 | -632,000 | -1,371,000 | -424,000 | -2,840,000 | -1,262,000 | -733,000 | -88,000 | -86,000 | -653,000 | -1,224,000 | -6,797,000 | |||||||||||||||||
benefit for losses on accounts and notes receivable | -45,000 | 53,000 | -57,000 | -8,000 | |||||||||||||||||||||||||||
unrealized and realized gain on investments | |||||||||||||||||||||||||||||||
changes in operating assets and liabilities | -9,421,000 | -14,581,000 | 34,244,000 | 12,692,000 | -21,699,000 | -9,961,000 | 41,476,000 | -41,182,000 | 7,388,000 | 53,647,000 | -68,217,000 | -34,718,000 | 26,927,000 | -21,156,000 | |||||||||||||||||
changes in advertising fund assets and liabilities, restricted | 8,799,000 | 27,433,000 | -9,095,000 | 10,138,000 | 23,803,000 | -31,925,000 | -46,382,000 | -2,958,000 | 18,940,000 | -22,331,000 | -13,073,000 | -6,763,000 | 10,248,000 | -7,907,000 | -3,842,000 | -7,822,000 | |||||||||||||||
net cash from operating activities | 185,396,000 | 187,784,000 | 179,076,000 | 178,018,000 | 172,729,000 | 150,686,000 | 123,464,000 | 168,734,000 | 179,839,000 | 127,609,000 | 114,682,000 | 145,163,000 | 176,739,000 | 74,626,000 | 78,789,000 | 169,605,000 | 222,401,000 | 172,404,000 | 123,043,000 | 131,681,000 | 116,898,000 | 124,656,000 | 124,478,000 | 73,454,000 | 92,737,000 | 43,219,000 | 19,008,000 | 36,344,000 | 6,908,000 | 51,081,000 | 4,573,000 |
cash flows from investing activities: | |||||||||||||||||||||||||||||||
capital expenditures | -21,436,000 | -20,486,000 | -14,745,000 | -42,084,000 | -27,118,000 | -23,502,000 | -20,181,000 | -46,125,000 | -21,291,000 | -18,949,000 | -19,031,000 | -36,726,000 | -17,844,000 | -20,210,000 | -12,454,000 | -43,520,000 | -16,968,000 | -51,114,000 | -20,301,000 | -29,448,000 | -39,110,000 | -26,086,000 | -12,321,000 | -6,588,000 | -6,269,000 | -3,566,000 | -13,895,000 | -19,071,000 | |||
free cash flows | 163,960,000 | 167,298,000 | 164,331,000 | 135,934,000 | 145,611,000 | 127,184,000 | 103,283,000 | 122,609,000 | 158,548,000 | 108,660,000 | 95,651,000 | 108,437,000 | 158,895,000 | 54,416,000 | 66,335,000 | 126,085,000 | 106,075,000 | 65,784,000 | 104,355,000 | 95,030,000 | 34,344,000 | 66,651,000 | 30,898,000 | 12,420,000 | 30,075,000 | 3,342,000 | 37,186,000 | -14,498,000 | |||
sale of investments | 0 | ||||||||||||||||||||||||||||||
proceeds from sale of assets | 0 | 1,577,000 | 278,000 | 2,260,000 | 3,358,000 | 2,256,000 | -2,430,000 | 1,601,000 | 4,171,000 | ||||||||||||||||||||||
other | 578,000 | -1,292,000 | -1,225,000 | -242,000 | 183,000 | 28,000 | -1,305,000 | -939,000 | 468,000 | -639,000 | -572,000 | 653,000 | -940,000 | 933,000 | -1,368,000 | 209,000 | 224,000 | -796,000 | -1,255,000 | 2,468,000 | -3,654,000 | -3,059,000 | -4,749,000 | 889,000 | 2,409,000 | -993,000 | |||||
net cash from investing activities | -20,858,000 | 30,765,000 | -15,970,000 | 40,666,000 | -26,935,000 | -23,474,000 | -21,486,000 | -46,903,000 | -20,823,000 | -19,588,000 | -19,603,000 | 5,016,000 | -18,784,000 | -19,277,000 | -20,636,000 | -52,377,000 | -37,831,000 | -24,763,000 | -610,000 | -22,937,000 | -44,929,000 | -22,942,000 | -117,159,000 | -82,758,000 | -120,543,000 | -12,762,000 | -30,939,000 | -9,743,000 | -3,023,000 | 1,884,000 | -17,572,000 |
cash flows from financing activities: | |||||||||||||||||||||||||||||||
proceeds from issuance of long-term debt | 0 | 0 | 0 | 0 | 1,300,000,000 | 58,134,000 | 0 | 780,000,000 | -60,000,000 | -39,908,000 | |||||||||||||||||||||
repayments of long-term debt and finance lease obligations | -1,145,912,000 | -1,215,000 | -646,000 | -1,700,000 | -1,183,000 | -1,239,000 | -13,525,000 | -14,356,000 | -14,163,000 | -13,287,000 | -13,899,000 | -134,235,000 | -13,913,000 | -13,667,000 | -13,861,000 | -14,019,000 | -8,974,000 | ||||||||||||||
proceeds from exercise of stock options | 563,000 | 4,790,000 | 7,529,000 | 1,355,000 | 3,202,000 | 20,693,000 | 10,774,000 | 2,850,000 | 4,755,000 | 708,000 | 343,000 | 2,016,000 | 770,000 | 260,000 | 266,000 | 3,734,000 | 832,000 | 355,000 | 5,934,000 | 6,388,000 | -18,406,000 | -2,069,000 | 125,000 | 1,133,000 | 1,978,000 | -2,456,000 | |||||
purchases of common stock | -74,657,000 | -153,041,000 | -50,000,000 | -114,558,000 | -189,999,000 | 0 | -25,000,000 | -58,178,000 | -90,000,000 | -90,764,000 | -30,083,000 | -1,000 | -196,078,000 | -50,000,000 | -47,661,000 | -216,215,000 | -93,696,000 | -51,532,000 | -16,392,000 | -600,007,000 | 0 | -54,413,000 | |||||||||
tax payments for restricted stock upon vesting | -2,390,000 | -314,000 | -8,158,000 | -392,000 | -1,446,000 | -2,560,000 | -6,700,000 | -170,000 | -2,172,000 | -1,515,000 | -1,553,000 | -29,000 | -8,296,000 | -1,606,000 | -789,000 | -3,000 | -3,253,000 | -63,000 | -41,000 | 11,000 | -38,000 | -2,281,000 | |||||||||
payments of common stock dividends and equivalents | -59,246,000 | -59,640,000 | -617,000 | -103,930,000 | -52,915,000 | -52,757,000 | -343,000 | -84,208,000 | -42,634,000 | -42,841,000 | -89,000 | -77,842,000 | -40,027,000 | -39,611,000 | -51,000 | -68,181,000 | -26,918,000 | -39,668,000 | -36,377,000 | -32,188,000 | -13,635,000 | 151,234,000 | |||||||||
cash paid for financing costs | 0 | 0 | -112,000 | ||||||||||||||||||||||||||||
net cash from financing activities | -296,929,000 | -209,420,000 | -51,892,000 | -219,225,000 | -242,341,000 | -35,863,000 | -34,794,000 | -139,164,000 | -144,214,000 | -147,699,000 | -45,281,000 | -211,685,000 | -137,544,000 | -104,624,000 | -62,096,000 | -294,684,000 | -292,816,000 | 23,505,000 | -132,009,000 | -150,734,000 | -97,278,000 | -87,992,000 | 93,191,000 | 8,765,000 | 2,500,000 | -9,153,000 | 12,716,000 | -1,467,000 | 25,012,000 | 29,717,000 | 25,001,000 |
effect of exchange rate changes on cash | -361,000 | 1,552,000 | 296,000 | -1,565,000 | 401,000 | -318,000 | -672,000 | 644,000 | -798,000 | 680,000 | -186,000 | -352,000 | 24,000 | -1,009,000 | 374,000 | -374,000 | 28,000 | ||||||||||||||
change in cash and cash equivalents, restricted cash and cash equivalents | -132,752,000 | 10,681,000 | 111,510,000 | -2,106,000 | -96,146,000 | 91,031,000 | 66,512,000 | -16,689,000 | 14,004,000 | -38,998,000 | 49,612,000 | -61,858,000 | 20,435,000 | -50,284,000 | -3,569,000 | -177,830,000 | -107,789,000 | 171,207,000 | -9,548,000 | -42,255,000 | |||||||||||
cash and cash equivalents, beginning of period | 0 | 0 | 186,126,000 | 0 | 0 | 0 | 114,098,000 | 0 | 0 | 0 | 60,356,000 | 0 | 0 | 0 | 148,160,000 | 0 | 0 | ||||||||||||||
restricted cash and cash equivalents, beginning of period | 0 | 0 | 195,370,000 | 0 | 0 | 0 | 200,870,000 | 0 | 0 | 0 | 191,289,000 | 0 | 0 | 0 | 180,579,000 | 0 | 0 | ||||||||||||||
cash and cash equivalents included in advertising fund assets, restricted, beginning of period | 0 | 0 | 80,928,000 | 0 | 0 | 0 | 88,165,000 | 0 | 0 | 0 | 143,559,000 | 0 | 0 | 0 | 161,741,000 | 0 | 0 | ||||||||||||||
cash and cash equivalents, restricted cash and cash equivalents and cash and cash equivalents included in advertising fund assets, restricted, beginning of period | 0 | 0 | 462,424,000 | 0 | 0 | 0 | 403,133,000 | 0 | 0 | 0 | 395,204,000 | 0 | 0 | 0 | 490,480,000 | 0 | 0 | ||||||||||||||
cash and cash equivalents, end of period | -133,131,000 | -31,461,000 | 304,320,000 | -2,958,000 | -94,615,000 | 79,805,000 | 203,894,000 | 33,219,000 | 3,859,000 | -77,173,000 | 154,193,000 | -54,420,000 | 423,000 | -50,609,000 | 164,962,000 | -147,192,000 | -41,553,000 | ||||||||||||||
restricted cash and cash equivalents, end of period | -9,233,000 | 14,322,000 | 197,412,000 | 9,931,000 | -11,580,000 | -12,733,000 | 209,752,000 | -1,437,000 | 12,613,000 | 18,896,000 | 170,798,000 | 6,725,000 | 26,349,000 | -10,026,000 | 168,241,000 | -25,695,000 | 24,579,000 | ||||||||||||||
cash and cash equivalents included in advertising fund assets, restricted, end of period | 9,612,000 | 27,820,000 | 72,202,000 | -9,079,000 | 10,049,000 | 23,959,000 | 55,999,000 | -48,471,000 | -2,468,000 | 19,279,000 | 119,825,000 | -14,163,000 | -6,337,000 | 10,351,000 | 153,708,000 | -4,943,000 | 7,426,000 | ||||||||||||||
cash and cash equivalents, restricted cash and cash equivalents and cash and cash equivalents included in advertising fund assets, restricted, end of period | -132,752,000 | 10,681,000 | 573,934,000 | -2,106,000 | -96,146,000 | 91,031,000 | 469,645,000 | -16,689,000 | 14,004,000 | -38,998,000 | 444,816,000 | -61,858,000 | 20,435,000 | -50,284,000 | 486,911,000 | -177,830,000 | -9,548,000 | ||||||||||||||
unrealized and realized (gain) loss on investments | |||||||||||||||||||||||||||||||
refranchising loss | 0 | 25,000 | 133,000 | 0 | 0 | 149,000 | |||||||||||||||||||||||||
unrealized (gain) loss on investments | -24,027,000 | ||||||||||||||||||||||||||||||
refranchising gain | |||||||||||||||||||||||||||||||
benefit from losses on accounts and notes receivable | -59,000 | 139,000 | 130,000 | 176,000 | 594,000 | 572,000 | 666,000 | 544,000 | 864,000 | 1,462,000 | 127,000 | ||||||||||||||||||||
changes in operating assets and liabilities: | |||||||||||||||||||||||||||||||
accounts receivable | |||||||||||||||||||||||||||||||
inventories, prepaid expenses and other | |||||||||||||||||||||||||||||||
accounts payable and accrued liabilities | |||||||||||||||||||||||||||||||
insurance reserves | |||||||||||||||||||||||||||||||
operating lease assets and liabilities | |||||||||||||||||||||||||||||||
advertising fund assets and liabilities, restricted | |||||||||||||||||||||||||||||||
purchases of franchise operations and other assets | |||||||||||||||||||||||||||||||
unrealized gain on investments | -4,446,000 | -34,258,000 | |||||||||||||||||||||||||||||
unrealized loss on investments | -11,398,000 | 18,699,000 | |||||||||||||||||||||||||||||
excess tax (benefits) deficiencies from equity-based compensation | -8,104,000 | ||||||||||||||||||||||||||||||
changes in accounts receivable | |||||||||||||||||||||||||||||||
changes in inventories, prepaid expenses and other | |||||||||||||||||||||||||||||||
changes in accounts payable and accrued liabilities | |||||||||||||||||||||||||||||||
changes in insurance reserves | |||||||||||||||||||||||||||||||
changes in operating lease assets and liabilities | |||||||||||||||||||||||||||||||
purchase of investments | -9,082,000 | ||||||||||||||||||||||||||||||
purchase of franchise operations and other assets | 0 | 0 | -6,814,000 | ||||||||||||||||||||||||||||
excess tax deficiencies (benefits) from equity-based compensation | 298,000 | ||||||||||||||||||||||||||||||
benefit from deferred income taxes | -5,659,000 | 3,422,000 | 1,171,000 | 1,319,000 | -649,000 | 74,000 | -6,085,000 | 6,828,000 | |||||||||||||||||||||||
maturities of advertising fund investments, restricted | 15,000,000 | ||||||||||||||||||||||||||||||
cash flows provided by | |||||||||||||||||||||||||||||||
exchange rate changes | |||||||||||||||||||||||||||||||
non-cash compensation expense | 4,680,000 | 6,442,000 | 6,220,000 | 6,435,000 | 5,690,000 | 9,804,000 | 4,139,000 | 8,277,000 | 3,097,000 | 1,511,000 | 384,000 | ||||||||||||||||||||
cash flows from | |||||||||||||||||||||||||||||||
gain on sale/disposal of assets | |||||||||||||||||||||||||||||||
purchases of advertising fund investments, restricted | |||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||
(gain) loss on sale/disposal of assets | |||||||||||||||||||||||||||||||
repayments of long-term debt and capital lease obligations | -8,100,000 | -44,742,000 | -559,205,000 | -180,000 | 1,434,973,000 | -116,161,000 | |||||||||||||||||||||||||
losses on sale/disposal of assets | |||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities- | |||||||||||||||||||||||||||||||
(gains) losses on sale/disposal of assets | 2,858,000 | ||||||||||||||||||||||||||||||
changes in operating assets and liabilities- | |||||||||||||||||||||||||||||||
increase in accounts receivable | |||||||||||||||||||||||||||||||
decrease (increase) in inventories, prepaid expenses and other | |||||||||||||||||||||||||||||||
increase in accounts payable and accrued liabilities | |||||||||||||||||||||||||||||||
increase in insurance reserves | |||||||||||||||||||||||||||||||
change in restricted cash | |||||||||||||||||||||||||||||||
proceeds from exercises of stock options | |||||||||||||||||||||||||||||||
effect of exchange rate changes on cash and cash equivalents | -283,000 | -888,000 | 433,000 | 458,000 | 618,000 | 114,000 | -568,000 | 112,000 | -13,000 | -283,000 | 497,000 | ||||||||||||||||||||
change in cash and cash equivalents | -25,592,000 | 12,834,000 | 100,943,000 | -81,000 | -24,688,000 | ||||||||||||||||||||||||||
cash and cash equivalents, at beginning of period | 0 | 0 | 0 | 0 | 4,521,000 | -5,553,000 | 2,980,000 | 0 | 38,222,000 | -26,523,000 | 5,995,000 | ||||||||||||||||||||
cash and cash equivalents, at end of period | -25,592,000 | 12,834,000 | 100,943,000 | -81,000 | -20,167,000 | 15,865,000 | 3,197,000 | 25,246,000 | 67,106,000 | 55,876,000 | 18,494,000 | ||||||||||||||||||||
changes in restricted cash | |||||||||||||||||||||||||||||||
tax impact from equity-based compensation | -6,650,000 | -2,030,000 | -16,684,000 | -9,876,000 | |||||||||||||||||||||||||||
increase in inventories, prepaid expenses and other | |||||||||||||||||||||||||||||||
gains on sale/disposal of assets | |||||||||||||||||||||||||||||||
amortization of deferred financing costs | |||||||||||||||||||||||||||||||
amortization of deferred financing costs, debt discount and other | 5,294,000 | 5,957,000 | 5,769,000 | ||||||||||||||||||||||||||||
amortization of deferred financing costs and other | |||||||||||||||||||||||||||||||
payments of common stock dividends | |||||||||||||||||||||||||||||||
proceeds from issuance of common stock | 3,984,000 | 978,000 | 1,167,000 | ||||||||||||||||||||||||||||
purchase of common stock | 123,806,000 | -1,846,000 | |||||||||||||||||||||||||||||
tax payments for restricted stock | |||||||||||||||||||||||||||||||
gains on debt extinguishment | -47,701,000 | ||||||||||||||||||||||||||||||
increase in cash and cash equivalents | 28,884,000 | ||||||||||||||||||||||||||||||
tax benefit from exercise of stock options | 1,167,000 | 17,392,000 | |||||||||||||||||||||||||||||
tax payments for performance-based restricted stock | |||||||||||||||||||||||||||||||
tax impact of stock options and restricted stock | |||||||||||||||||||||||||||||||
repayments of long-term debt and capital lease obligation | -44,502,000 | -107,000 | -736,656,000 | 14,851,000 | -115,488,000 | ||||||||||||||||||||||||||
tax benefit from stock options | -277,000 | 32,000 | |||||||||||||||||||||||||||||
common stock dividends and equivalents | |||||||||||||||||||||||||||||||
proceeds from issuance of long-term debt and capital lease obligations | |||||||||||||||||||||||||||||||
tax impact of stock options | |||||||||||||||||||||||||||||||
decrease (increase) in accounts receivable | |||||||||||||||||||||||||||||||
decrease in accounts payable and accrued liabilities | |||||||||||||||||||||||||||||||
change in restricted cash and cash equivalents | |||||||||||||||||||||||||||||||
amortization and write-off of deferred financing costs and debt discount | 10,215,000 | ||||||||||||||||||||||||||||||
proceeds from sale of property, plant and equipment | -9,075,000 | ||||||||||||||||||||||||||||||
repurchase of common stock | -67,000 | ||||||||||||||||||||||||||||||
cash paid for financing fees | -22,255,000 | ||||||||||||||||||||||||||||||
net proceeds from issuance of common stock | 1,690,000 | ||||||||||||||||||||||||||||||
proceeds from sale of equity investment | |||||||||||||||||||||||||||||||
repayments of notes receivable | |||||||||||||||||||||||||||||||
capital contribution and other | |||||||||||||||||||||||||||||||
amortization of deferred financing costs and debt discount | 452,000 | 5,751,000 | |||||||||||||||||||||||||||||
proceeds from sale of equity investments | |||||||||||||||||||||||||||||||
purchase of cumulative preferred stock | |||||||||||||||||||||||||||||||
distributions | |||||||||||||||||||||||||||||||
common stock dividends | -12,024,000 | ||||||||||||||||||||||||||||||
decrease in cash and cash equivalents | |||||||||||||||||||||||||||||||
acquisitions of franchise operations | |||||||||||||||||||||||||||||||
dividends | |||||||||||||||||||||||||||||||
capital contribution | |||||||||||||||||||||||||||||||
dividends paid | |||||||||||||||||||||||||||||||
proceeds from the issuance of long-term debt | |||||||||||||||||||||||||||||||
repayments of debt | |||||||||||||||||||||||||||||||
net proceeds from the issuance of common stock | |||||||||||||||||||||||||||||||
purchases of preferred stock |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
